Programme

November 2016 by Martin Turner

 

7th Neuroimaging Society in ALS


***Trinity Biomedical Sciences Institute, Dublin***

 PROGRAMME

 

SATURDAY 10th DECEMBER

1100-1115

Welcome and brief review of the year in ALS imaging
Martin Turner (UK)

1115-1200

KEYNOTE

35 + 10 minutes

The selective anatomical vulnerability of ALS:
‘disease-defining’ and ‘disease-defying’ brain regions

Peter Bede (Ireland)

1200-1300

RESEARCH PRESENTATIONS 1

10 + 5 minutes each

Increased in vivo glial activation in patients with PLS assessed with [11C]-PBR28 PET
Sabrina Paganoni (USA)

Structural organization of the brain connectome in patients with PLS
Silvia Basaia (Italy)

Relationship between brain metabolism on FDG-PET and cognitive/behavioural functioning in ALS
Joke De Vocht (Belgium)

Gray matter correlates of cognitive decline in ALS: a multi-atlas based MRI study
Marcondes França Jr (Brazil)

 1300-1400

LUNCH

 1400-1530                                            

EMERGING APPLICATIONS

25 + 5 minutes each

fMRI in the spinal cord
Falk Eippert (UK)

Longitudinal MRI-based ALS staging: concepts and applications
Jan Kassubek (Germany)

7T DTI of ex vivo ALS brains and pathological correlates
Mary-Kay Floeter (USA)

 1530-1600

COFFEE

1600-1800                                         

RESEARCH PRESENTATIONS 2

10 + 5 minutes each

The neuroanatomical substrate of pseudobulbar affect in ALS: a multimodal neuroimaging study
Foteini Christidi (Greece)

The metabolic signature of spreading TDP 43 pathology in ALS patients
Donatienne Van Weehaeghe (Belgium)  

Volumetric analysis of the hypothalamus in ALS
Martin Gorges (Germany)

Effects of motor neuron disease progression on cortical beta and gamma rhythms:
Longitudinal case studies of ALS using MEG
Michael Lee (Australia)

Data-driven modelling of diffusion MRI changes in ALS
indicates evolution of distal prior to proximal corticospinal tract pathology
Matt Gabel (UK)

The association of motor symptom development and thickness
of functional regions within the motor cortex in ALS
Bram Nitert (Netherlands)

Tracking longitudinal evolution of ALS using diffusion tensor MRI
Pilar M. Ferraro (Italy)

The progression of cerebral pathology in ALS: A six-monthly multi-modal MRI study over two years
Ricarda Menke (UK)

 1830-

DINNER




SUNDAY 11th DECEMBER

 0900-0930

ELECTIONS

Steering Committee

 0930-1100                                         

RESEARCH PRESENTATIONS 3

10 + 5 minutes each

 Glial activation measured by [11C]-PBR28 PET correlates with 1H-MRS brain metabolites in ALS
Eva-Maria Ratai (USA)

Survival and neuroimaging in ALS
Henk-Jan Westeneng (Netherlands)

Combined NODDI and quantitative magnetization transfer (qMT) imaging provides new insights into ALS
Rebecca Broad (UK)

Brain Sodium MRI depicts upper motor neuron involvement in ALS
Aude-Marie Grapperon (France)

Resting state functional connectivity in C9orf72 mutation carriers: genotype and phenotypes
Rachel Smallwood (USA)

Association of cognitive impairment and intrinsic functional connectivity of the fronto-temporal network
Dorothée Lulé (Germany)

1100-1130

COFFEE

1130-1300

RESEARCH PRESENTATIONS 4

10 + 5 minutes each

MEG cortico-muscular coherence to assess corticospinal tract integrity in ALS
Malcolm Proudfoot (UK)

A connectivity-based analysis of frontostriatal and cortico-basal networks in ALS
Peter Bede (Ireland)

Sequential PET and MRI in a patient with ALS-FTD reveals worsening brain metabolism
and cortical thinning with disease progression
Erik Pioro (USA)

MRI-based staging in the ALS-FTD spectrum: application to bvFTD
Hans-Peter Müller (Germany)

Imaging muscle denervation in MND using whole-body MRI
Tom Jenkins (UK)

In vivo correlates of pathological diagnosis in clinical variants of primary progressive aphasia
Edoardo G Spinelli (Italy)

 1300-1400

LUNCH

 1400-1500

IMAGING CONSORTIA UPDATES


 DISCUSSION AND CLOSE